摘要 |
N-Arylphenylacetamide derivatives represented by the following formula [I]: (wherein R<SUP>1 </SUP>is C<SUB>1-6 </SUB>alkoxy, etc.; R<SUP>2 </SUP>is hydrogen, -(CH<SUB>2</SUB>)<SUB>m</SUB>-N(R<SUP>6</SUP>)(R<SUP>7</SUP>) (m is an integer of from 1 to 4; R<SUP>6 </SUP>is hydrogen, C<SUB>1-4 </SUB>alkyl, etc., R<SUP>7 </SUP>is hydrogen, etc.), etc.; R<SUP>3 </SUP>is hydrogen, halogen, etc.; R<SUP>4 </SUP>is C<SUB>6-10 </SUB>alkyl, -Y-R<SUP>8 </SUP>(Y is a single bond, C<SUB>1-6 </SUB>alkylene, C<SUB>2-6 </SUB>alkenylene, C<SUB>2-6 </SUB>alkynylene, etc., R<SUP>8 </SUP>is aryl, C<SUB>3-8 </SUB>cycloalkyl, C<SUB>6-15 </SUB>polycycloalkyl, etc.), etc.; R<SUP>5 </SUP>is hydrogen, etc.; and X<SUP>1 </SUP>is hydrogen), or pharmaceutically acceptable salts thereof or hydrates or solvates of the same, and a pharmaceutical composition containing the same. These compounds are useful as preventives and/or remedies giving no pain at the early stage of administration, which are efficacious in oral administration and have potent analgesic and antiinflammatory effects.
|